106 related articles for article (PubMed ID: 2550704)
1. Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites.
Ruenitz PC; Thompson CB; Srivatsan V
J Steroid Biochem; 1989 Sep; 33(3):365-9. PubMed ID: 2550704
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone.
Jones CD; Blaszczak LC; Goettel ME; Suarez T; Crowell TA; Mabry TE; Ruenitz PC; Srivatsan V
J Med Chem; 1992 Mar; 35(5):931-8. PubMed ID: 1548683
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
Borras M; Jin L; Bouhoute A; Legros N; Leclercq G
Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690
[TBL] [Abstract][Full Text] [Related]
4. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
5. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of nitromiphene (CI 628) in the immature female rat: role of gastrointestinal microflora in the biotransformation of a triarylethylene antiestrogen.
Ruenitz PC; Bagley JR
Cancer Res; 1986 Dec; 46(12 Pt 1):6255-9. PubMed ID: 3536077
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
[TBL] [Abstract][Full Text] [Related]
9. Biological potency and uterine estrogen receptor interactions of the metabolites of the antiestrogens CI628 and U23,469.
Hayes JR; Rorke EA; Robertson DW; Katzenellenbogen BS; Katzenellenbogen JA
Endocrinology; 1981 Jan; 108(1):164-72. PubMed ID: 7007017
[No Abstract] [Full Text] [Related]
10. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
11. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of oxygenated sterols: positive correlation with binding affinities for the antiestrogen-binding sites.
Lin L; Hwang PL
Biochim Biophys Acta; 1991 Mar; 1082(2):177-84. PubMed ID: 2007181
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogenic effects of LY 117018 in MCF-7 cells.
Scholl SM; Huff KK; Lippman ME
Endocrinology; 1983 Aug; 113(2):611-7. PubMed ID: 6872943
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C
Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor in rabbit ovaries and effects of antiestrogen on progesterone production.
Holt JA; Lorincz MA; Lyttle CR
Endocrinology; 1981 Jun; 108(6):2308-15. PubMed ID: 7014198
[No Abstract] [Full Text] [Related]
16. Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site.
Berthois Y; Pons M; Dussert C; Crastes de Paulet A; Martin PM
Mol Cell Endocrinol; 1994 Mar; 99(2):259-68. PubMed ID: 8206333
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
Ferguson ER; Katzenellenbogen BS
Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
[TBL] [Abstract][Full Text] [Related]
18. Phenolic metabolites of clomiphene: [(E,Z)-2-[4-(1,2-diphenyl-2-chlorovinyl)phenoxy]ethyl]diethylamine. Preparation, electrophilicity, and effects in MCF 7 breast cancer cells.
Ruenitz PC; Arrendale RF; Schmidt WF; Thompson CB; Nanavati NT
J Med Chem; 1989 Jan; 32(1):192-7. PubMed ID: 2909731
[TBL] [Abstract][Full Text] [Related]
19. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
20. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
